70.43 USD
-0.78 (-1.1%)
70.43 USD
0 (0%)
HALO gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. HALO has an excellent profitability rating, but there are some minor concerns on its financial health. An interesting combination arises when we look at growth and value: HALO is growing strongly while it also seems undervalued. With these ratings, HALO could be worth investigating further for value and growth investing!.
1. Profitability
1.1 Basic Checks
- In the past year HALO was profitable.
- HALO had a positive operating cash flow in the past year.
- Each year in the past 5 years HALO has been profitable.
- Each year in the past 5 years HALO had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 26.81%, HALO belongs to the best of the industry, outperforming 97.71% of the companies in the same industry.
- With an excellent Return On Equity value of 118.17%, HALO belongs to the best of the industry, outperforming 99.62% of the companies in the same industry.
- HALO has a better Return On Invested Capital (42.77%) than 99.24% of its industry peers.
- HALO had an Average Return On Invested Capital over the past 3 years of 17.81%. This is in line with the industry average of 18.07%.
- The 3 year average ROIC (17.81%) for HALO is below the current ROIC(42.77%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.81% | ||
| ROE | 118.17% | ||
| ROIC | 42.77% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
- HALO has a Profit Margin of 47.91%. This is amongst the best in the industry. HALO outperforms 98.29% of its industry peers.
- In the last couple of years the Profit Margin of HALO has declined.
- Looking at the Operating Margin, with a value of 59.33%, HALO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- HALO's Operating Margin has declined in the last couple of years.
- The Gross Margin of HALO (84.55%) is better than 87.24% of its industry peers.
- HALO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 59.33% | ||
| PM (TTM) | 47.91% | ||
| GM | 84.55% |
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HALO is creating value.
- Compared to 1 year ago, HALO has less shares outstanding
- The number of shares outstanding for HALO has been reduced compared to 5 years ago.
- HALO has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.13 indicates that HALO is not in any danger for bankruptcy at the moment.
- The Altman-Z score of HALO (5.13) is better than 73.33% of its industry peers.
- HALO has a debt to FCF ratio of 2.51. This is a good value and a sign of high solvency as HALO would need 2.51 years to pay back of all of its debts.
- The Debt to FCF ratio of HALO (2.51) is better than 93.14% of its industry peers.
- A Debt/Equity ratio of 1.59 is on the high side and indicates that HALO has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.59, HALO is not doing good in the industry: 76.95% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 2.51 | ||
| Altman-Z | 5.13 |
ROIC/WACC5.34
WACC8.01%
2.3 Liquidity
- A Current Ratio of 1.59 indicates that HALO should not have too much problems paying its short term obligations.
- HALO has a worse Current ratio (1.59) than 80.00% of its industry peers.
- A Quick Ratio of 1.37 indicates that HALO should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.37, HALO is not doing good in the industry: 81.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 48.55% over the past year.
- Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.12% on average per year.
- HALO shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.19%.
- The Revenue has been growing by 38.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)48.55%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%35.43%
Revenue 1Y (TTM)31.19%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%22.12%
3.2 Future
- The Earnings Per Share is expected to grow by 17.78% on average over the next years. This is quite good.
- HALO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.23% yearly.
EPS Next Y51.29%
EPS Next 2Y40.02%
EPS Next 3Y32.08%
EPS Next 5Y17.78%
Revenue Next Year33.53%
Revenue Next 2Y29.85%
Revenue Next 3Y23.95%
Revenue Next 5Y13.23%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 12.51 indicates a correct valuation of HALO.
- HALO's Price/Earnings ratio is rather cheap when compared to the industry. HALO is cheaper than 97.52% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, HALO is valued rather cheaply.
- The Price/Forward Earnings ratio is 8.49, which indicates a very decent valuation of HALO.
- 98.86% of the companies in the same industry are more expensive than HALO, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of HALO to the average of the S&P500 Index (23.94), we can say HALO is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.51 | ||
| Fwd PE | 8.49 |
4.2 Price Multiples
- HALO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HALO is cheaper than 96.57% of the companies in the same industry.
- HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 97.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.75 | ||
| EV/EBITDA | 10.75 |
4.3 Compensation for Growth
- HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of HALO may justify a higher PE ratio.
- HALO's earnings are expected to grow with 32.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y40.02%
EPS Next 3Y32.08%
5. Dividend
5.1 Amount
- HALO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
70.43
-0.78 (-1.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)N/A N/A
Inst Owners105.85%
Inst Owner Change0.93%
Ins Owners0.81%
Ins Owner Change-0.62%
Market Cap8.28B
Revenue(TTM)1.24B
Net Income(TTM)595.49M
Analysts76
Price Target78.67 (11.7%)
Short Float %11.87%
Short Ratio5.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.41%
Min EPS beat(2)3.56%
Max EPS beat(2)19.26%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.56%
Max EPS beat(4)19.26%
EPS beat(8)7
Avg EPS beat(8)12.2%
EPS beat(12)10
Avg EPS beat(12)9.54%
EPS beat(16)13
Avg EPS beat(16)9.68%
Revenue beat(2)2
Avg Revenue beat(2)6.93%
Min Revenue beat(2)2.18%
Max Revenue beat(2)11.69%
Revenue beat(4)4
Avg Revenue beat(4)7.01%
Min Revenue beat(4)1.36%
Max Revenue beat(4)12.81%
Revenue beat(8)6
Avg Revenue beat(8)5.71%
Revenue beat(12)7
Avg Revenue beat(12)2.94%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)1.48%
PT rev (3m)3.35%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)1.04%
EPS NY rev (1m)0%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.51 | ||
| Fwd PE | 8.49 | ||
| P/S | 6.66 | ||
| P/FCF | 13.75 | ||
| P/OCF | 13.56 | ||
| P/B | 16.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.75 |
EPS(TTM)5.63
EY7.99%
EPS(NY)8.29
Fwd EY11.77%
FCF(TTM)5.12
FCFY7.27%
OCF(TTM)5.2
OCFY7.38%
SpS10.57
BVpS4.28
TBVpS-2.22
PEG (NY)0.24
PEG (5Y)N/A
Graham Number23.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.81% | ||
| ROE | 118.17% | ||
| ROCE | 53.28% | ||
| ROIC | 42.77% | ||
| ROICexc | 86.79% | ||
| ROICexgc | N/A | ||
| OM | 59.33% | ||
| PM (TTM) | 47.91% | ||
| GM | 84.55% | ||
| FCFM | 48.47% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
ROICexc(3y)23.94%
ROICexc(5y)N/A
ROICexgc(3y)71.73%
ROICexgc(5y)N/A
ROCE(3y)22.19%
ROCE(5y)37.11%
ROICexgc growth 3Y-1.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.16%
ROICexc growth 5YN/A
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 2.51 | ||
| Debt/EBITDA | 0.98 | ||
| Cap/Depr | 10.51% | ||
| Cap/Sales | 0.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 101.16% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.13 |
F-Score8
WACC8.01%
ROIC/WACC5.34
Cap/Depr(3y)13.62%
Cap/Depr(5y)33.32%
Cap/Sales(3y)1.21%
Cap/Sales(5y)0.98%
Profit Quality(3y)118.15%
Profit Quality(5y)93.9%
High Growth Momentum
Growth
EPS 1Y (TTM)48.55%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%35.43%
EPS Next Y51.29%
EPS Next 2Y40.02%
EPS Next 3Y32.08%
EPS Next 5Y17.78%
Revenue 1Y (TTM)31.19%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%22.12%
Revenue Next Year33.53%
Revenue Next 2Y29.85%
Revenue Next 3Y23.95%
Revenue Next 5Y13.23%
EBIT growth 1Y54.59%
EBIT growth 3Y25.97%
EBIT growth 5YN/A
EBIT Next Year61.82%
EBIT Next 3Y38.25%
EBIT Next 5Y15.57%
FCF growth 1Y70.36%
FCF growth 3Y16.28%
FCF growth 5YN/A
OCF growth 1Y65.76%
OCF growth 3Y16.96%
OCF growth 5YN/A
HALOZYME THERAPEUTICS INC / HALO FAQ
Can you provide the ChartMill fundamental rating for HALOZYME THERAPEUTICS INC?
ChartMill assigns a fundamental rating of 7 / 10 to HALO.
Can you provide the valuation status for HALOZYME THERAPEUTICS INC?
ChartMill assigns a valuation rating of 9 / 10 to HALOZYME THERAPEUTICS INC (HALO). This can be considered as Undervalued.
Can you provide the profitability details for HALOZYME THERAPEUTICS INC?
HALOZYME THERAPEUTICS INC (HALO) has a profitability rating of 8 / 10.
What is the financial health of HALOZYME THERAPEUTICS INC (HALO) stock?
The financial health rating of HALOZYME THERAPEUTICS INC (HALO) is 6 / 10.
Can you provide the expected EPS growth for HALO stock?
The Earnings per Share (EPS) of HALOZYME THERAPEUTICS INC (HALO) is expected to grow by 51.29% in the next year.